Pulike Biological Engineering

Pulike Biological Engineering EBIT

The EBIT of Pulike Biological Engineering (603566.SS) as of Oct 19, 2026 is 190.14 M CNY. In the previous year, EBIT was 97.79 M CNY — a change of 94.44% (higher).

EBIT

190.14 MCNY

YoY

94.44%

Last updated:

In 2025, Pulike Biological Engineering's EBIT was 190.14 M CNY, a 94.44% increase from the 97.79 M CNY EBIT recorded in the previous year.

The Pulike Biological Engineering EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2021
284.58 M CNY
Jan 1, 2022
176.92 M CNY
Jan 1, 2023
193.01 M CNY
Jan 1, 2024
97.79 M CNY
Jan 1, 2025
190.14 M CNY
Jan 1, 2026 (e)
178.48 M CNY
Jan 1, 2027 (e)
193.63 M CNY
Jan 1, 2028 (e)
266.37 M CNY
The Pulike Biological Engineering EBIT history
YEAREBITYoY
est266.37 MCNY+37.56%
est193.63 MCNY+8.49%
est178.48 MCNY-6.13%
190.14 MCNY+94.44%
97.79 MCNY-49.33%
193.01 MCNY+9.10%
176.92 MCNY-37.83%
284.58 MCNY+31.42%
216.55 MCNY+102.61%
106.88 MCNY-21.83%
136.74 MCNY+26.74%
107.89 MCNY-41.06%
183.07 MCNY+18.64%
154.30 MCNY-2.10%
157.61 MCNY-6.76%
169.04 MCNY+16.45%
145.17 MCNY+9.67%
132.36 MCNY+42.40%
92.95 MCNY-14.79%
109.09 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Pulike Biological Engineering Revenue

Pulike Biological Engineering Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
1.10 B CNY
284.58 M CNY
244.14 M CNY
Jan 1, 2022
1.23 B CNY
176.92 M CNY
167.82 M CNY
Jan 1, 2023
1.25 B CNY
193.01 M CNY
174.52 M CNY
Jan 1, 2024
1.04 B CNY
97.79 M CNY
92.81 M CNY
Jan 1, 2025
1.09 B CNY
190.14 M CNY
184.99 M CNY
Jan 1, 2026 (e)
1.03 B CNY
178.48 M CNY
161.55 M CNY
Jan 1, 2027 (e)
1.09 B CNY
193.63 M CNY
175.30 M CNY
Jan 1, 2028 (e)
1.39 B CNY
266.37 M CNY
230.30 M CNY

Pulike Biological Engineering Margins

Pulike Biological Engineering stock margins

The Pulike Biological Engineering margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Pulike Biological Engineering. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Pulike Biological Engineering.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
65.41 %
25.91 %
22.22 %
Jan 1, 2022
62.63 %
14.38 %
13.64 %
Jan 1, 2023
61.01 %
15.41 %
13.93 %
Jan 1, 2024
61.09 %
9.38 %
8.90 %
Jan 1, 2025
59.87 %
17.45 %
16.97 %
Jan 1, 2026 (e)
59.87 %
17.38 %
15.73 %
Jan 1, 2027 (e)
59.87 %
17.75 %
16.07 %
Jan 1, 2028 (e)
59.87 %
19.15 %
16.56 %

Pulike Biological Engineering Stock analysis

What does Pulike Biological Engineering do? Pulike Biological Engineering Inc, listed on the Shanghai Stock Exchange with ticker 603566.SS and ISIN CNE1000025N0, is a pharmaceutical company based in Luoyang, China. The company went public on May 18, 2015. It employs 1,718 people and operates within the healthcare sector, specifically in the pharmaceuticals industry. Pulike Biological Engineering focuses on the research, development, manufacturing, and sale of biological products for animals, chemical drugs, and Chinese veterinary drugs. The company's veterinary biological products include vaccines and antibodies, which are used for the prevention and control of infectious diseases in poultry and livestock. Its veterinary chemical medicines are primarily used for treating epidemic diseases affecting poultry and livestock. The company is headquartered in Luoyang, Henan, and its website is http://www.pulike.com.cn/. Pulike Biological Engineering Inc is engaged in the research, development, production, and distribution of veterinary biological products and chemical medicines. The firm's product portfolio targets the prevention and treatment of diseases in animals, with a focus on poultry and livestock health management. Pulike Biological Engineering is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Pulike Biological Engineering's EBIT

Pulike Biological Engineering's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Pulike Biological Engineering's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Pulike Biological Engineering's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Pulike Biological Engineering’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Pulike Biological Engineering stock

EBIT of Pulike Biological Engineering is 190.14 M CNY in 2025.

EBIT of Pulike Biological Engineering changed from 97.79 M CNY to 190.14 M CNY, representing a 94.44% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Pulike Biological Engineering since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Pulike Biological Engineering historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Pulike Biological Engineering

All Key Metrics — Pulike Biological Engineering